MYCN and neuroblastoma: This mutational scenario was enriched in high-risk non-MYCN-amplified neuroblastomas, suggesting that the high number of CNAs and SVs found in this risk group might be caused by the portrayed HRR deficiency, which is in line with recent reports in other cancer types.50